Pharmacological Abortion in a Pandemic: An Italian Medico-Legal Perspective

Int J Environ Res Public Health. 2021 Nov 16;18(22):12043. doi: 10.3390/ijerph182212043.

Abstract

The limitations caused by the spread of the SARS-CoV2 virus have had repercussions on the voluntary termination of pregnancy. During the pandemic, Italy issued updated guidelines regarding voluntary termination of pregnancy by means of mifepristone and prostaglandin. This included news concerning the time limit and location in which this procedure could be accessed: updates partially recognize women's needs, and they are into line with the European parliament's recent exhortations. However, these updates do not change the previously provided responsibilities that lie with doctors. This article aimed to compare regulations concerning medical abortion in Italy and other countries, with a focus on recent Italian updates in the context of pandemic.

Keywords: COVID-19; RU486; abortion; legal medicine; mifepristone; pandemic.

MeSH terms

  • Abortion, Induced*
  • COVID-19*
  • Female
  • Humans
  • Italy / epidemiology
  • Pandemics
  • Pregnancy
  • RNA, Viral
  • SARS-CoV-2

Substances

  • RNA, Viral